The full speaker list for this conference has not yet been announced. Please check back in the coming weeks for further information.

Charles Bernick, MD, Associate Medical Director, Lou Ruvo Center for Brain Health, Cleveland Clinic

Mikael Brönnegård, MD., Ph.D., Associate Professor, Karolinska Institute, Chief Executive Officer, NeuroVive Pharmaceutical AB

Stuart Blincko, Ph.D., Sr. Principal Research Scientist, Abbott Diagnostics

Peter Como, Ph.D. (tentative), Lead Reviewer, Neuropsychologist, Division of Ophthalmic, Neurological & Ear, Nose & Throat Devices (DONED), Neurodiagnostic and Neurotherapeutic Devices Branch (NNDB), US Food & Drug Administration

Nicholas Conti, Ph.D., Vice President, Business Development, Quest Diagnostics

Ralph G DePalma, MD, FACS, Special Operations Officer, VA Office of Research & Development, Professor of Surgery, Uniformed Services University of the Health Sciences

Ramon Diaz-Arrastia, MD, Ph.D., Professor of Neurology, Uniformed Services University of the Health Sciences, Director of Clinical Research, Center for Neuroscience & Regenerative Medicine

Alan Faden, MD, David S. Brown Professor in Trauma, Professor, Departments of Anesthesiology, Anatomy & Neurobiology, Neurosurgery, and Neurology, Director, Center for Shock, Trauma & Anesthesiology Research (STAR), University of Maryland School of Medicine

Sam Gandy, MD, Ph.D., Professor of Neurology and Psychiatry (Dual Primary Appointments), Mount Sinai Chair in Alzheimer’s Disease Research, Director, Mount Sinai Center for Cognitive Health and NFL Neurological Care, Associate Director, Mount Sinai Alzheimer’s Disease Research Center, Mount Sinai School of Medicine and James J Peters VA Medical Center

Joshua Gatson, Ph.D., Assistant Professor, Division of Burn/Trauma/Critical Care, Department of Surgery, UT Southwestern Medical Center

Larry Glass, CEO, Neuren Pharmaceuticals

Ronald L. Hayes, Ph.D., Founder & President, Banyan Biomarkers

Kim A. Heidenreich, Ph.D., Professor, Department of Pharmacology, Neuroscience Program, University of Colorado School of Medicine, Anschutz Medical Center

Graham Hubler, Ph.D., Director, Sydney Kimmel Institute for Nuclear Renaissance (SKINR), Department of Physics and Astronomy, University of Missouri

Andreas Jeromin, Ph.D., Chief Scientific Officer, NextGen Sciences

Andrew Maas, MD, Ph.D., Professor & Chairman, Department of Neurosurgery, University Hospital Antwerp

Thomas W. MacAllister, JD, Ph.D., President & Chief Executive Officer, BHR Pharma, LLC

Geoffrey T. Manley, MD, Ph.D., Professor and Vice Chairman of Neurological Surgery, University of California, San Francisco, Chief of Neurosurgery, San Francisco General Hospital, Co-Director, Brain and Spinal Injury Center (BASIC)

Andrew Mayer, Ph.D., Associate Professor of Translational Neuroscience, The Mind Research Network, Adjunct Assistant Professor of Neurology and Psychology, University of New Mexico

Guy Miller, MD, Ph.D., Chairman and Chief Executive Officer, Edison Pharmaceuticals, Inc.

Mark Mintun, MD, Chief Medical Officer, Avid Radiopharmaceuticals (Eli Lilly & Co.)

Gregory P. Mueller, Ph.D., Professor, Vice Chair for Research, Uniformed Services University of the Health Sciences

Giulio Maria Pasinetti, MD, Ph.D., Professor of Psychiatry, Neuroscience, Geriatrics and Adult Development, Department of Psychiatry, Mount Sinai School of Medicine

Daniel Perl, MD, Professor of Pathology (Neuropathology), Uniformed Services University of the Health Sciences

Paul Rapp, Ph.D., Professor of Military and Emergency Medicine, Uniformed Services University, Director, Traumatic Injury Research Program

Roger Sabbadini, Ph.D., Vice President & Founder, Lpath, Inc.

Deborah A. Shear, Ph.D., Neuroprotection Section Chief, Brain Trauma Neuroprotection and Neurorestoration Branch, Center for Military Psychiatry and Neuroscience (CMPN), Walter Reed Army Institute of Research

Martha Shenton, Ph.D., Professor and Director, Psychiatry Neuroimaging Laboratory, Department of Psychiatry,  Brigham and Women's Hospital, Harvard Medical School

Adam J. Simon, Ph.D., President & CEO, Cerora, Inc.

Robert A. Stern, Ph.D., Professor of Neurology and Neurosurgery, Center for the Study of Traumatic Encephalopathy, Director, Clinical Core, BU Alzheimer's Disease Center, Boston University School of Medicine

Frank Tegtmeier, Ph.D., Chief Scientific Officer, vasopharm

Jeff Victoroff, MD, Associate Professor Clinical Neurology & Psychiatry, University of Southern California School of Medicine